Literature DB >> 7400941

Decomposition of aminophylline in suppository formulations.

J F Brower, E C Juenge, D P Page, M L Dow.   

Abstract

An aminophylline suppository product, when stored at room temperature, was found to be deficient in ethylenediamine content by the USP XIX assay and by a specific method for primary amines. The product also had a melting point that was considerably higher than body temperature. An accelerated decomposition experiment, conducted on normal suppositories of identical original composition, yielded a product refractory at steam bath temperatures and containing no ethylenediamine measurable by the USP assay. The suppositories from both the original sample and the decomposition experiment contained considerable amounts of a white material, which melted at similar to or approximately 150 degrees and which consisted of the diamide products formed by the reaction of ethylenediamine and the fatty acids present in coconut and palm kernel oils. The results, which confirmed the work of Cieszynski, showed that the ethylenediamine constituent of aminophylline can react with suppository base materials to produce insoluble amide decomposition products.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400941     DOI: 10.1002/jps.2600690820

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Rectal motility and bioavailability.

Authors:  J J Tukker; C J de Blaey; G A Charbon
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

2.  Pulsed proton NMR and solid-liquid fat ratio determinations in suppository vehicles and aminophylline suppositories.

Authors:  C J De Blaey; F A Varkevisser; A Kalk
Journal:  Pharm Weekbl Sci       Date:  1984-10-19

3.  Prolonged storage of aminophylline suppositories. The impact on physical parameters and bioavailability.

Authors:  J J Tukker; C J De Blaey
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

4.  Serum theophylline levels after use of an anhydrous crystalline theophylline suppository.

Authors:  J Aarbakke; A Høylandskjaer; O N Gamst
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.